In the age of smartphones and virtual reality, NHS trusts must evolve their approach to reach patients, and can look towards a future of clinically proven personalised digital therapeutic t
Paul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk about the landscape for digital health and the company’s plans for the space, in
In the 20th century, research, technology and new novel treatments have enabled us to increase the average lifespan by 25 years, but our healthspan has not increased accordingly.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
